Real-time Quantitative PCR Detecting System



Previous PostDark horse in multi-cancer screening? Sword Edge targets Galleri!Next PostNavigate BioPharma Services collaborates with Becton Dickinson to jointly develop clinical solutions for companion diagnostics using Becton Dickinson’s flow cytometry technology
KEEP READING...

You may also like

default, Innovations
•May 20, 2024

A safe and inexpensive innovative blood sampling device developed by ETH Zurich

default, Leading lab updates
•May 13, 2024

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis

default, Regulatory insights
•May 11, 2024

FDA issuing Final Rule on regulating LDT